Time-homogeneous Markov process for HIV/AIDS progression under a combination treatment therapy: cohort study, South Africa

Table 9 Transition for the WHO Stage Baseline Line

Transition	1	2	3	4
1 to 2	0.3143	0.1289	0.0529	0.0217
1 to 6	0.0044	0.0041	0.0038	0.0035
1 to 7	0.0139	0.0103	0.0076	0.0057
2 to 1	0.8460	0.8758	0.9066	0.9384
2 to 3	0.1250	0.1119	0.1001	0.0896
2 to 6	0.0171	0.0182	0.0194	0.0207
2 to 7	0.0139	0.1286	0.0119	0.0109
3 to 2	0.8116	1.2320	1.8700	2.8390
3 to 4	0.8856	1.1970	1.6170	2.1850
3 to 6	0.0072	0.0081	0.0091	0.0102
3 to 7	0.0305	0.0245	0.0197	0.0159
4 to 3	4.5930	5.0750	5.6070	6.1950
4 to 5	1.2360	1.0240	0.8484	0.7028
4 to 6	0.0139	0.0165	0.0195	0.0232
4 to 7	0.0325	0.0226	0.0157	0.0109
5 to 4	67.220	56.630	47.710	40.190
5 to 6	0.0390	0.0596	0.0912	0.1394
5 to 7	0.5792	0.3253	0.1827	0.1026

ISSN: 1742-4682